Product Description
Mechanisms of Action: 5-HT2A Antagonist,GPIIb/IIIa Inhibitor
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: India | Korea
Approved Indications: None
Known Adverse Events: None
Company: Daewoong
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Phase 4: Diabetic Nephropathy|Peripheral Arterial Disease|Kidney Diseases|Angina Pectoris, Variant|Thrombophilia|Coronary Artery Disease|Peripheral Vascular Diseases|Kidney Failure, Chronic|Arterial Occlusive Diseases|Myocardial Ischemia|Intermittent Claudication
Phase 3: Ischemic Stroke|Peripheral Arterial Disease|Coronary Artery Disease|Kidney Failure, Chronic|Peripheral Vascular Diseases
Phase 1: Healthy Volunteers|Peripheral Arterial Disease|Chronic Pain|Hypertension|Malnutrition
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| SEUMC 2023-10-009 | N/A |
Not yet recruiting |
Intermittent Claudication|Stroke|Atherosclerosis |
2028-06-30 |
|
| YMC047 | P4 |
Completed |
Coronary Artery Disease|Peripheral Vascular Diseases|Peripheral Arterial Disease|Myocardial Ischemia |
2024-02-28 |
|
| YMC044 | P4 |
Completed |
Arterial Occlusive Diseases|Intermittent Claudication |
2023-03-09 |
|
| DWAP_P401 | N/A |
Completed |
Arterial Occlusive Diseases |
2022-01-20 |
|
| BE | P1 |
Completed |
Healthy Volunteers |
2020-10-26 |
|
| YMC036 | P4 |
Completed |
Peripheral Arterial Disease|Thrombophilia |
2019-12-26 |
|
| Sarpogrelate | P1 |
Unknown status |
Malnutrition |
2019-05-13 |
50% |
| Sarpogrelate | P1 |
Completed |
Healthy Volunteers |
2019-05-06 |
|
| NCT01674686 | P4 |
Unknown status |
Angina Pectoris, Variant |
2018-12-31 |
|
| SAFE | P4 |
Unknown status |
Peripheral Vascular Diseases|Peripheral Arterial Disease |
2019-01-01 |
|
| DDS17-035BE | P1 |
Completed |
Healthy Volunteers |
2018-08-21 |
17% |
| DDS17-034BE | P1 |
Completed |
Healthy Volunteers |
2018-08-21 |
17% |
| CTR20171098 | P1 |
Completed |
Chronic Pain |
2018-01-06 |
|
| CTR20160023 | N/A |
Completed |
Chronic Pain |
2016-12-01 |
|
| SAGE-CAD | P4 |
Completed |
Myocardial Ischemia|Coronary Artery Disease |
2016-02-01 |
|
| ChiCTR-IPR-14005534 | N/A |
Recruiting |
Thrombosis |
2015-11-10 |
|
| ChiCTR-IPR-14005567 | N/A |
Recruiting |
Thrombosis |
2015-11-10 |
|
| SONATA Study | P4 |
Completed |
Diabetic Nephropathy|Kidney Diseases |
2014-11-17 |
|
| DAVICI | P3 |
Completed |
Peripheral Vascular Diseases|Peripheral Arterial Disease |
2014-04-01 |
|
| DDI-102 | P1 |
Completed |
Hypertension|Peripheral Arterial Disease |
2014-01-01 |
|
| CTR20130158 | N/A |
Completed |
Chronic Pain |
2013-10-31 |
|
| AGU-65 | N/A |
Unknown status |
Atherosclerosis |
2012-10-01 |
|
| SERENADE | P3 |
Completed |
Coronary Artery Disease|Kidney Failure, Chronic |
2012-03-01 |
|
| KUP-SPG3-101 | P1 |
Completed |
Healthy Volunteers |
2011-11-01 |
|
| DP-SACL-I-003 | P1 |
Completed |
Healthy Volunteers |
2011-08-01 |